Glycerol Monolaurate, an Analogue to a Factor Secreted by <italic toggle="yes">Lactobacillus</italic>, Is Virucidal against Enveloped Viruses, Including HIV-1

ABSTRACT The vaginal microbiota influences sexual transmission of human immunodeficiency virus type 1 (HIV-1). Colonization of the vaginal tract is normally dominated by Lactobacillus species. Both Lactobacillus and Enterococcus faecalis may secrete reutericyclin, which inhibits the growth of a vari...

Full description

Bibliographic Details
Main Authors: Jennifer L. Welch, Jinhua Xiang, Chioma M. Okeoma, Patrick M. Schlievert, Jack T. Stapleton
Format: Article
Language:English
Published: American Society for Microbiology 2020-06-01
Series:mBio
Subjects:
Online Access:https://journals.asm.org/doi/10.1128/mBio.00686-20
_version_ 1818856675041345536
author Jennifer L. Welch
Jinhua Xiang
Chioma M. Okeoma
Patrick M. Schlievert
Jack T. Stapleton
author_facet Jennifer L. Welch
Jinhua Xiang
Chioma M. Okeoma
Patrick M. Schlievert
Jack T. Stapleton
author_sort Jennifer L. Welch
collection DOAJ
description ABSTRACT The vaginal microbiota influences sexual transmission of human immunodeficiency virus type 1 (HIV-1). Colonization of the vaginal tract is normally dominated by Lactobacillus species. Both Lactobacillus and Enterococcus faecalis may secrete reutericyclin, which inhibits the growth of a variety of pathogenic bacteria. Increasing evidence suggests a potential therapeutic role for an analogue of reutericyclin, glycerol monolaurate (GML), against microbial pathogens. Previous studies using a macaque vaginal simian immunodeficiency virus (SIV) transmission model demonstrated that GML reduces transmission and alters immune responses to infection in vitro. Previous studies showed that structural analogues of GML negatively impact other enveloped viruses. We sought to expand understanding of how GML inhibits HIV-1 and other enveloped viruses and show that GML restricts HIV-1 entry post-CD4 engagement at the step of coreceptor binding. Further, HIV-1 and yellow fever virus (YFV) particles were more sensitive to GML interference than particles “matured” by proteolytic processing. We show that high-pressure-liquid-chromatography (HPLC)-purified reutericyclin and reutericyclin secreted by Lactobacillus inhibit HIV-1. These data emphasize the importance and protective nature of the normal vaginal flora during viral infections and provide insights into the antiviral mechanism of GML during HIV-1 infection and, more broadly, to other enveloped viruses. IMPORTANCE A total of 340 million sexually transmitted infections (STIs) are acquired each year. Antimicrobial agents that target multiple infectious pathogens are ideal candidates to reduce the number of newly acquired STIs. The antimicrobial and immunoregulatory properties of GML make it an excellent candidate to fit this critical need. Previous studies established the safety profile and antibacterial activity of GML against both Gram-positive and Gram-negative bacteria. GML protected against high-dose SIV infection and reduced inflammation, which can exacerbate disease, during infection. We found that GML inhibits HIV-1 and other human-pathogenic viruses (yellow fever virus, mumps virus, and Zika virus), broadening its antimicrobial range. Because GML targets diverse infectious pathogens, GML may be an effective agent against the broad range of sexually transmitted pathogens. Further, our data show that reutericyclin, a GML analog expressed by some lactobacillus species, also inhibits HIV-1 replication and thus may contribute to the protective effect of Lactobacillus in HIV-1 transmission.
first_indexed 2024-12-19T08:28:16Z
format Article
id doaj.art-57159630436f46228a167a5f2ac212d0
institution Directory Open Access Journal
issn 2150-7511
language English
last_indexed 2024-12-19T08:28:16Z
publishDate 2020-06-01
publisher American Society for Microbiology
record_format Article
series mBio
spelling doaj.art-57159630436f46228a167a5f2ac212d02022-12-21T20:29:15ZengAmerican Society for MicrobiologymBio2150-75112020-06-0111310.1128/mBio.00686-20Glycerol Monolaurate, an Analogue to a Factor Secreted by <italic toggle="yes">Lactobacillus</italic>, Is Virucidal against Enveloped Viruses, Including HIV-1Jennifer L. Welch0Jinhua Xiang1Chioma M. Okeoma2Patrick M. Schlievert3Jack T. Stapleton4Department of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USADepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USADepartment of Pharmacology, Stony Brook University School of Medicine, Stony Brook, New York, USADepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USADepartment of Microbiology and Immunology, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USAABSTRACT The vaginal microbiota influences sexual transmission of human immunodeficiency virus type 1 (HIV-1). Colonization of the vaginal tract is normally dominated by Lactobacillus species. Both Lactobacillus and Enterococcus faecalis may secrete reutericyclin, which inhibits the growth of a variety of pathogenic bacteria. Increasing evidence suggests a potential therapeutic role for an analogue of reutericyclin, glycerol monolaurate (GML), against microbial pathogens. Previous studies using a macaque vaginal simian immunodeficiency virus (SIV) transmission model demonstrated that GML reduces transmission and alters immune responses to infection in vitro. Previous studies showed that structural analogues of GML negatively impact other enveloped viruses. We sought to expand understanding of how GML inhibits HIV-1 and other enveloped viruses and show that GML restricts HIV-1 entry post-CD4 engagement at the step of coreceptor binding. Further, HIV-1 and yellow fever virus (YFV) particles were more sensitive to GML interference than particles “matured” by proteolytic processing. We show that high-pressure-liquid-chromatography (HPLC)-purified reutericyclin and reutericyclin secreted by Lactobacillus inhibit HIV-1. These data emphasize the importance and protective nature of the normal vaginal flora during viral infections and provide insights into the antiviral mechanism of GML during HIV-1 infection and, more broadly, to other enveloped viruses. IMPORTANCE A total of 340 million sexually transmitted infections (STIs) are acquired each year. Antimicrobial agents that target multiple infectious pathogens are ideal candidates to reduce the number of newly acquired STIs. The antimicrobial and immunoregulatory properties of GML make it an excellent candidate to fit this critical need. Previous studies established the safety profile and antibacterial activity of GML against both Gram-positive and Gram-negative bacteria. GML protected against high-dose SIV infection and reduced inflammation, which can exacerbate disease, during infection. We found that GML inhibits HIV-1 and other human-pathogenic viruses (yellow fever virus, mumps virus, and Zika virus), broadening its antimicrobial range. Because GML targets diverse infectious pathogens, GML may be an effective agent against the broad range of sexually transmitted pathogens. Further, our data show that reutericyclin, a GML analog expressed by some lactobacillus species, also inhibits HIV-1 replication and thus may contribute to the protective effect of Lactobacillus in HIV-1 transmission.https://journals.asm.org/doi/10.1128/mBio.00686-20coronavirusglycerol monolaurateLactobacillusmumps virusreutericyclinviruses
spellingShingle Jennifer L. Welch
Jinhua Xiang
Chioma M. Okeoma
Patrick M. Schlievert
Jack T. Stapleton
Glycerol Monolaurate, an Analogue to a Factor Secreted by <italic toggle="yes">Lactobacillus</italic>, Is Virucidal against Enveloped Viruses, Including HIV-1
mBio
coronavirus
glycerol monolaurate
Lactobacillus
mumps virus
reutericyclin
viruses
title Glycerol Monolaurate, an Analogue to a Factor Secreted by <italic toggle="yes">Lactobacillus</italic>, Is Virucidal against Enveloped Viruses, Including HIV-1
title_full Glycerol Monolaurate, an Analogue to a Factor Secreted by <italic toggle="yes">Lactobacillus</italic>, Is Virucidal against Enveloped Viruses, Including HIV-1
title_fullStr Glycerol Monolaurate, an Analogue to a Factor Secreted by <italic toggle="yes">Lactobacillus</italic>, Is Virucidal against Enveloped Viruses, Including HIV-1
title_full_unstemmed Glycerol Monolaurate, an Analogue to a Factor Secreted by <italic toggle="yes">Lactobacillus</italic>, Is Virucidal against Enveloped Viruses, Including HIV-1
title_short Glycerol Monolaurate, an Analogue to a Factor Secreted by <italic toggle="yes">Lactobacillus</italic>, Is Virucidal against Enveloped Viruses, Including HIV-1
title_sort glycerol monolaurate an analogue to a factor secreted by italic toggle yes lactobacillus italic is virucidal against enveloped viruses including hiv 1
topic coronavirus
glycerol monolaurate
Lactobacillus
mumps virus
reutericyclin
viruses
url https://journals.asm.org/doi/10.1128/mBio.00686-20
work_keys_str_mv AT jenniferlwelch glycerolmonolaurateananaloguetoafactorsecretedbyitalictoggleyeslactobacillusitalicisvirucidalagainstenvelopedvirusesincludinghiv1
AT jinhuaxiang glycerolmonolaurateananaloguetoafactorsecretedbyitalictoggleyeslactobacillusitalicisvirucidalagainstenvelopedvirusesincludinghiv1
AT chiomamokeoma glycerolmonolaurateananaloguetoafactorsecretedbyitalictoggleyeslactobacillusitalicisvirucidalagainstenvelopedvirusesincludinghiv1
AT patrickmschlievert glycerolmonolaurateananaloguetoafactorsecretedbyitalictoggleyeslactobacillusitalicisvirucidalagainstenvelopedvirusesincludinghiv1
AT jacktstapleton glycerolmonolaurateananaloguetoafactorsecretedbyitalictoggleyeslactobacillusitalicisvirucidalagainstenvelopedvirusesincludinghiv1